ArticleBMC biotechnology2026

A TXNIP-driven bioluminescent reporter for high-throughput discovery of glycolytic inhibitors against renal cell carcinoma.

Yajie Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.